News

Cancer informatics and digital pathology solution provider Inspirata announced earlier this week its free remote pathology initiative, available to healthcare institutions looking to provide flexibility to their staff during COVID-19. In an important boost to this campaign, Inspirata is...

Gilead Sciences said it is donating 1.5 million doses of its experimental anti-coronavirus drug remdesivir, which could potentially treat 140,000 severely ill patients. The doses are available for compassionate use, expanded access and clinical trials and will be donated for...

BiologIC Technologies, a pioneer in powerful digital architectures for radically disruptive automation hardware in synthetic biology, has announced today that it is accelerating development using the recently launched J826 3D printer from Stratasys, a global leader in additive manufacturing...

The Pharma & Biopharma Outsourcing Association (PBOA), a trade group that represents Contract Manufacturing Organizations (CMOs) and other service providers in the bio/pharmaceutical sector, reports that many of its member companies are actively involved in helping their clients develop...

Mount Sinai Health System is helping health care providers to care for COVID-19 patients who are recovering at home. With the platform, providers can monitor the patients’ symptoms and adjust care as necessary, including sending the patient to the...

GlaxoSmithKline has teamed up with Xiamen Innovax Biotech to evaluate a vaccine against the novel coronavirus behind the COVID-19 pandemic. The agreement gives Innovax access to a GSK adjuvant to enhance the immune response triggered by its recombinant protein-based...

Ergomed plc , a company focused on providing specialised services to the pharmaceutical industry, announces it is providing support for a clinical development programme for namilumab, a monoclonal antibody therapy targeting granulocyte-macrophage colony stimulating factor (GM-CSF), for the treatment...